Eagle Health Investments’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-42,909
Closed -$5.96M 27
2023
Q2
$5.96M Hold
42,909
1.12% 23
2023
Q1
$3.9M Buy
42,909
+40,706
+1,848% +$5.53M 0.76% 21
2022
Q4
$302K Sell
2,203
-26,095
-92% -$8.83M 0.07% 27
2022
Q3
$24.5M Sell
28,298
-9,869
-26% -$6.19M 5.63% 7
2022
Q2
$16.7M Buy
38,167
+8,616
+29% +$4.49M 3.9% 12
2022
Q1
$18.8M Buy
29,551
+10,073
+52% +$6.35M 4.62% 11
2021
Q4
$17.4M Buy
19,478
+12,714
+188% +$13.4M 4.23% 12
2021
Q3
$8.58M Buy
6,764
+1,803
+36% +$2.18M 2.72% 17
2021
Q2
$6M Hold
4,961
2.06% 19
2021
Q1
$6.57M Buy
4,961
+3,078
+163% +$4.36M 2.58% 16
2020
Q4
$2.52M Buy
+1,883
New +$2.15M 1.62% 19

Other funds holding CANO

Eagle Health Investments's CANO Position: Q3 2023 in Review

Eagle Health Investments sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 42,909 shares — an estimated $5.96M sold.

Eagle Health Investments first reported a position in CANO in Q4 2020 and held it in 11 quarters. The position peaked at $24.5M in Q3 2022. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

  • Eagle Health Investments reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
  • Eagle Health Investments sold 42,909 Cano Health, Inc. shares in Q3 2023, an estimated $5.96M.
  • Eagle Health Investments first reported a position in Cano Health, Inc. in Q4 2020 and held it in 11 quarters.
  • Eagle Health Investments's Cano Health, Inc. position peaked at $24.5M in Q3 2022.
  • 134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Eagle Health Investments's 13F filing for Q3 2023, filed 27 Oct 2023.